Insmed Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Insmed Inc inventory turnover ratio, the Insmed Inc's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.43 in the second quarter 2026, a new company high. Average inventory processing period, for the Insmed Inc in Jun 30 2026 quarter, has decreased to 255 days, compare to 302 days, in the Mar 31 2026 quarter.

Within Healthcare sector 271 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1106 in the first quarter 2026, to 1539.

INSM Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Insmed Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

INSM Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	32.32 %	31.97 %	33.97 %	22.84 %	19.48 %
Y / Y Cost of Sales Growth	139.4 %	122.86 %	69.09 %	38.71 %	33.92 %
Inventory Turnover Ratio (TTM)	1.43	1.21	1.07	0.98	0.95
INSM's Total Ranking	# 1539	# 1106	# 794	# 1413	#
Average inventory processing period	256	302	342	372	383
Seq. Inventory Growth	7.13 %	0.64 %	9.18 %	12.42 %	6.84 %
Seq. Cost of Sales Growth	41.74 %	7.24 %	50.59 %	4.59 %	31.94 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 74
Healthcare Sector	# 272
Overall Market	# 1539

Inventory Turnover Ratio Statistics
High	Average	Low
1.43	0.94	0.72
(Jun 30 2026)		(Dec 31 2021)

INSM Company Profile >> Back to INSM Efficiency Comparisons >> Compare INSM Inventory Turnover Ratio to its Competitors

Financial Statements
Insmed Inc's Inventories	$ 142 Millions	Visit INSM's Balance sheet
Insmed Inc's Cost of Revenues TTM	$ 188 Millions	Visit INSM's Income Statement
What are INSM's Sales?		Visit INSM's Sales by Segment

Other Inventory Turnover Ratios
Insmed Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
INSM's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for INSM's Competitors
Inventory Turnover Ratio for INSM's Suppliers
Inventory Turnover Ratio for INSM's Customers

You may also want to know
INSM's Sales Growth Rates	INSM's Pe Price to earnings ratio	INSM's Receivables Turnover Ratio	INSM's Stock Quote
INSM's Net Income Growth Rates	INSM's Ps Price to Sales ratio	INSM's Sales per Employee	INSM's Asset Turnover Ratio
INSM's Net Margin	INSM's Pb Price to Book ratio	INSM's Financial Strength Ratios	INSM's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Neuraxis Inc	3.55	$ 0.783 Millions	$ 0 Millions
Beyond Air Inc	3.51	$ 6.447 Millions	$ 2 Millions
Nexgel Inc	3.49	$ 7.577 Millions	$ 2 Millions
Lifeward ltd	3.47	$ 13.976 Millions	$ 4 Millions
Tandem Diabetes Care Inc	3.46	$ 456.703 Millions	$ 132 Millions
Mirum Pharmaceuticals Inc	3.40	$ 85.221 Millions	$ 25 Millions
Zai Lab Limited	3.39	$ 195.542 Millions	$ 58 Millions
Bellevue Life Sciences Acquisition Corp	3.38	$ 1.215 Millions	$ 0 Millions
Evolus Inc	3.37	$ 105.904 Millions	$ 31 Millions
Gilead Sciences Inc	3.35	$ 6,217.000 Millions	$ 1,857 Millions
10x Genomics Inc	3.29	$ 184.539 Millions	$ 56 Millions
Biofrontera Inc	3.28	$ 6.622 Millions	$ 2 Millions
Maravai Lifesciences Holdings Inc	3.22	$ 135.038 Millions	$ 42 Millions
Solventum Corporation	3.22	$ 3,421.000 Millions	$ 1,061 Millions
Agilent Technologies inc	3.20	$ 3,404.000 Millions	$ 1,064 Millions
Mettler toledo International Inc	3.18	$ 1,277.460 Millions	$ 401 Millions
Bionexus Gene Lab Corp	3.15	$ 2.362 Millions	$ 1 Millions
Zevra Therapeutics Inc	3.14	$ 6.180 Millions	$ 2 Millions
Prestige Consumer Healthcare Inc	3.13	$ 513.522 Millions	$ 164 Millions
Eton Pharmaceuticals Inc	3.11	$ 44.176 Millions	$ 14 Millions
Becton Dickinson And Company	3.09	$ 11,161.000 Millions	$ 3,615 Millions
Mimedx Group Inc	3.07	$ 75.981 Millions	$ 25 Millions
Revvity Inc	2.98	$ 1,136.473 Millions	$ 381 Millions
Amneal Pharmaceuticals Inc	2.98	$ 1,891.689 Millions	$ 635 Millions
Akebia Therapeutics Inc	2.96	$ 44.632 Millions	$ 15 Millions
Msa Safety Inc	2.92	$ 1,021.036 Millions	$ 350 Millions
Ligand Pharmaceuticals Incorporated	2.91	$ 32.387 Millions	$ 11 Millions
Logicmark Inc	2.83	$ 3.881 Millions	$ 1 Millions
Iovance Biotherapeutics inc	2.81	$ 152.872 Millions	$ 54 Millions
Livanova Plc	2.79	$ 468.065 Millions	$ 168 Millions

Date modified: 2026-09-08T13:52:09+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.